Stockscreener 앱 받기
1.99
1.53%
0.03
시간 외 거래:
2.04
0.05
+2.51%
Gossamer Bio Inc 주식(GOSS)의 최신 뉴스
Will Gossamer Bio Inc. continue its uptrendGold Moves & Smart Swing Trading Techniques - Newser
Automated trading signals detected on Gossamer Bio Inc.2025 Stock Rankings & Real-Time Chart Breakout Alerts - Newser
What machine learning models say about Gossamer Bio Inc.Portfolio Return Report & AI Enhanced Execution Alerts - Newser
Chartists Watching For Breakout in Gossamer Bio Inc.2025 Key Lessons & Fast Gain Swing Alerts - beatles.ru
Why Gossamer Bio Inc. is moving todayJuly 2025 Intraday Action & Daily Chart Pattern Signals - Newser
What institutional flow reveals about Gossamer Bio Inc.Weekly Trade Summary & Accurate Entry and Exit Point Alerts - Newser
Multi asset correlation models including Gossamer Bio Inc.Weekly Stock Report & Safe Capital Growth Trade Ideas - Newser
What is the earnings history of Gossamer Bio Inc.Global Markets & Fast Gaining Stock Reports - classian.co.kr
Gossamer Bio Revenue Estimates Surge Higher Amid Analyst Upgrades - AInvest
Analysts' Revenue Estimates For Gossamer Bio, Inc. (NASDAQ:GOSS) Are Surging Higher - Yahoo Finance
Pulmonary Hypertension associated with Interstitial Lung Disease Market to Witness Upsurge in Growth During the Forecast Period (2025–2034) | DelveInsight - GlobeNewswire Inc.
Gossamer Bio Inc.’s Beta Climbs After Market VolatilityJuly 2025 Summary & High Yield Stock Recommendations - classian.co.kr
Gossamer Bio (GOSS) Reports Q2 Loss, Beats Revenue Estimates - MSN
Gossamer Bio shares rise 1.52% after-hours following XOMA Royalty's acquisitions and pipeline advancements. - AInvest
Gossamer Bio Reports Q2 2025 Financial Results - TipRanks
Analyzing recovery setups for Gossamer Bio Inc. investorsAI-Powered Stock Trend Movement Analysis - Newser
Q3 EPS Estimates for Gossamer Bio Increased by HC Wainwright - Defense World
Wedbush Has Optimistic Outlook of Gossamer Bio Q3 Earnings - Defense World
Will Gossamer Bio Inc. see short term momentumStock Portfolio Risk and Return Analysis - Newser
Is Gossamer Bio Inc. stock poised for growthGrowth Watchlist for Long Term Positioning - Newser
Institutional investors in Gossamer Bio, Inc. (NASDAQ:GOSS) see US$54m decrease in market cap last week, although long-term gains have benefitted them. - Yahoo Finance
Is Gossamer Bio Inc. trending in predictive chart modelsOversold Stock Bounce Playbook Generator - Newser
What makes Gossamer Bio Inc. stock price move sharplyReal-Time Investment Signal Forecast with AI - Newser
Gossamer Bio (NASDAQ:GOSS) Stock Rating Lowered by Wall Street Zen - Defense World
Real time scanner hits for Gossamer Bio Inc. explainedMarket Timing Strategy with Technical Filters - Newser
Q3 EPS Estimates for Gossamer Bio Lowered by Leerink Partnrs - Defense World
H.C. Wainwright Maintains Gossamer Bio(GOSS.US) With Buy Rating, Maintains Target Price $10 - 富途牛牛
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)August 7, 2025 - BioSpace
Gossamer Bio earnings beat by $0.01, revenue topped estimates - Investing.com Australia
Gossamer Bio Reports Q2 2025 Financials, Announces PROSERA Phase 3 Topline Results Expected in February 2026, and First Site Activations for Registrational Phase 3 SERANATA Study in PH-ILD Expected in Q4 2025. - AInvest
Gossamer Bio 2025 Q2 Earnings Sharp Net Loss Amid Revenue Drop - AInvest
Gossamer Bio 2025 Q2 Earnings Sharp Net Income Decline of 177.7% - AInvest
Gossamer Bio shares fall 7.41% premarket despite beating earnings expectations. - AInvest
Gossamer Bio Inc. Exceeds Q2 Expectations Despite LossNews and Statistics - IndexBox
Gossamer Bio: Q2 Earnings Snapshot - New Haven Register
Gossamer Bio Announces Second Quarter 2025 Financial Results and Provides Business Update - BioSpace
How Gossamer Bio Inc. stock performs during market volatilityBuy and Exit Strategy Based on Momentum - Newser
Gossamer Bio shares rise 1.39% after-hours despite Q2 revenue drop of 88%. - AInvest
GOSS Achieves Strong Q2 Revenue and Prepares for Commercial Expa - GuruFocus
Gossamer Bio Reports Q2 Revenue Drop of 88% - AInvest
Gossamer Bio Q2 revenue drops 88% - MarketScreener
Gossamer Bio's 390-Patient PAH Trial Nears Crucial February Readout, $213M Cash Runway - Stock Titan
Will Gossamer Bio Inc. price bounce be sustainableFree Smart Trade Plans With Risk Protection - Newser
Can Gossamer Bio Inc. rally from current levelsStrategy Builder for Growth Focused Traders - Newser
Why is Gossamer Bio Inc. stock attracting strong analyst attentionExponentially increasing returns - Jammu Links News
Custom strategy builders for tracking Gossamer Bio Inc.Market Liquidity and Price Flow Analysis - Newser
Published on: 2025-08-04 06:30:01 - beatles.ru
Is Gossamer Bio Inc. forming a reversal patternReal-Time Investment Signal Forecast with AI - Newser
How volatile is Gossamer Bio Inc. stock compared to the marketCapitalize on market momentum for maximum gains - Jammu Links News
Why Gossamer Bio Inc. stock attracts strong analyst attentionLong-Term Allocation Strategy Summary Breakdown - Newser
What are the latest earnings results for Gossamer Bio Inc.Capitalize on fast-moving stock trends - Jammu Links News
What is the dividend policy of Gossamer Bio Inc. stockCapitalize on high-yield stocks early - Jammu Links News
When is Gossamer Bio Inc. stock expected to show significant growthFree Expert Stock Watchlist - Jammu Links News
How strong is Gossamer Bio Inc. company’s balance sheetUnlock daily trading alerts for profits - Jammu Links News
Is it the right time to buy Gossamer Bio Inc. stockCapitalize on stocks with high profit margins - Jammu Links News
1.18%
자본화:
|
볼륨(24시간):